Once an antibody latches on to a pathogen, broadly neutralizing antibodies inactivate it (as their name implies). This is ...

A study found that covid-19 vaccines appeared to awaken the immune system in lung and skin cancer patients, helping them live ...

In a quest to develop new antiviral drugs for COVID-19 and other diseases, a collaboration led by scientists at The Wertheim UF Scripps Institute has identified a potential new drug against the virus ...

A multi-institutional study led by researchers at the University of Alabama at Birmingham and the University of North Carolina at Chapel Hill has revealed a previously underappreciated mechanism by ...

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. Serine protease inhibitors (SERPINs) are ...

The global pandemic may be over, but SARS-CoV-2 continues to infect people around the world. Indeed, the United States has recorded roughly 750 deaths from COVID-19 over the past month. Now, an siRNA ...

This study analyzed the immunological mechanisms underlying the elicitation of broadly neutralizing antibodies (bnAbs) by a severeacute respiratory syndrome coronavirus 2 (SARS-CoV-2) bivalent vaccine ...

Neutralizing antibodies that merely block receptor binding are losing ground against heavily mutated SARS-CoV-2 Omicron sub-variants. A new approach now exploits a llama-derived nanobody—VHH21—that ...

Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Cluster of differentiation 147 (CD147), a transmembrane glycoprotein, has been ...

Imagine you're a molecular biologist wanting to launch a project seeking treatments for a newly emerging disease. You know you need the expertise of a virologist and an immunologist, plus a ...

Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. This randomised, observer ...